Literature DB >> 18170719

RETROLENTAL DECOMPRESSION FOR MALIGNANT GLAUCOMA.

A S Scott1, V H Smith.   

Abstract

Year:  1961        PMID: 18170719      PMCID: PMC510147          DOI: 10.1136/bjo.45.10.654

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  7 in total

1.  Malignant glaucoma.

Authors:  A G CROSS
Journal:  Br J Ophthalmol       Date:  1959-01       Impact factor: 4.638

2.  Malignant glaucoma.

Authors:  H L BIRGE
Journal:  Am J Ophthalmol       Date:  1957-03       Impact factor: 5.258

3.  A new operative procedure for the intracapsular extraction of cataract; the posterior (pars plana) route.

Authors:  J H YOUNG
Journal:  Trans Ophthalmol Soc U K       Date:  1957

4.  Lens extraction in the treatment of glaucoma.

Authors:  E TAMLER; A E MAUMENEE
Journal:  AMA Arch Ophthalmol       Date:  1955-12

5.  The role of vitreous detachment in aphakic and malignant glaucoma.

Authors:  R N SHAFFER
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1954 Mar-Apr

6.  Iridectomy in narrow-angle glaucoma.

Authors:  O BARKAN
Journal:  Am J Ophthalmol       Date:  1954-04       Impact factor: 5.258

7.  Malignant Glaucoma.

Authors:  P A Chandler
Journal:  Trans Am Ophthalmol Soc       Date:  1950
  7 in total
  3 in total

1.  Retinal detachment treated with intravitreal air: an evaluation of 241 cases.

Authors:  H B Chawla; J A Coleiro
Journal:  Br J Ophthalmol       Date:  1977-09       Impact factor: 4.638

2.  Evaluation of the Effectiveness of Surgical Treatment of Malignant Glaucoma in Pseudophakic Eyes through Partial PPV with Establishment of Communication between the Anterior Chamber and the Vitreous Cavity.

Authors:  Marek Rękas; Karolina Krix-Jachym; Tomasz Żarnowski
Journal:  J Ophthalmol       Date:  2015-08-12       Impact factor: 1.909

Review 3.  Acute and chronic fluid misdirection syndrome: pathophysiology and treatment.

Authors:  Andrzej Grzybowski; Piotr Kanclerz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-06       Impact factor: 3.535

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.